Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH207641FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥78,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥117,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (FDZJ), a subsidiary of Shanghai Pharmaceutical Co Ltd, is a bio-pharmaceutical company that develops, manufactures and markets genetic engineering drugs. The company offers bio-pharmaceutical products in the field of genetic engineering, photodynamic therapy and nano-drugs. Its products comprise aminolevulinic acid hydrochloride, hemoporfin for Injection and liposomal drugs include doxorubicin liposome among others. FDZJ also offers medical diagnostic products such as Down’s syndrome screening diagnostic reagent. It offers photodynamic therapy drug products such as aminolevulinic acid hydrochloride and hemoporfin for injection, among others. The company markets its products across China. FDZJ is headquartered in Shanghai, China

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Key Recent Developments

Apr 09,2021: Fudan Zhangjiang 2020 annual performance briefing meeting successfully concluded 2021-04-08
Mar 31,2021: Shanghai FudanZhangjiang Bio-Pharmaceutical announces Annual Results for the Year Ended 31 December 2020

This comprehensive SWOT profile of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Information
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Overview
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Employees
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Employee Biographies
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Operational Heads
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Major Products and Services
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – History
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Company Statement
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Locations And Subsidiaries
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Business Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Corporate Strategy
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Strengths
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Weaknesses
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Opportunities
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Threats
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Information
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Ratios
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Share Data
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Major Products and Services
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, History
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Employees
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Employee Biographies
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Operational Heads
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Other Locations
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Subsidiaries
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Key Competitors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, SWOT Analysis
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Ratios based on current share price
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Annual Ratios
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • California Pizza Kitchen, Inc.:企業の戦略的SWOT分析
    California Pizza Kitchen, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Petrogrand AB:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrogrand AB (Petrogrand), formerly Malka Oil AB is an oil and gas company that acquires, explores and produces crude oil and natural gas assets. The company carries out management and refining of Russian oil assets. It holds interests in the Nizhne-Paninsky license area located in northwes …
  • Edmond De Rothschild (Suisse) S.A.
    Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report Summary Edmond De Rothschild (Suisse) S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Balfour Beatty plc:企業の戦略・SWOT・財務情報
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Young’s Market Co LLC:企業の戦略的SWOT分析
    Young's Market Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Atox Bio Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atox Bio Ltd (Atox Bio) is a late state biotechnology company that develops immunomodulators to treat critically ill patients with severe infections. The company develops drugs for patients suffering from necrotizing soft tissue infections, a flesh eating bacteria. It implements novel mode o …
  • Power Assets Holdings Limited
    Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Power Assets Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Inhibitor Therapeutics Inc (INTI):企業の財務・戦略的SWOT分析
    Inhibitor Therapeutics Inc (INTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • AbCheck sro:製薬・医療:M&Aディール及び事業提携情報
    Summary AbCheck Sro (AbCheck), a subsidiary of Affimed NV is a healthcare technology company offers discovery and optimization of high-quality human antibodies. The company offers technology platforms such as Absieve, and AbAccel. Its Absieve is an antibody discovery technology that offers proprieta …
  • Probiogen AG:企業のM&A・事業提携・投資動向
    Probiogen AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Probiogen AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • GATX Corp (GATX):企業の財務・戦略的SWOT分析
    GATX Corp (GATX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Octapharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Octapharma AG (Octapharma) is a human protein manufacturer that focuses on developing and producing human proteins from human plasma and cell lines. The company treats patients worldwide with products across immunotherapy (immune disorders), haematology (coagulation disorders), and critical …
  • Koninklijke Philips N.V. (PHIA)-医療機器分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • Kimball International, Inc.:企業の戦略・SWOT・財務分析
    Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kimball International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bryte Insurance Company Ltd:企業の戦略・SWOT・財務情報
    Bryte Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bryte Insurance Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Allianz France S.A.:企業の戦略・SWOT・財務情報
    Allianz France S.A. - Strategy, SWOT and Corporate Finance Report Summary Allianz France S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Reliance Worldwide Corporation Ltd (RWC):企業の財務・戦略的SWOT分析
    Reliance Worldwide Corporation Ltd (RWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Bank of Japan (8301):企業の財務・戦略的SWOT分析
    Bank of Japan (8301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CITIC Securities Company Limited:企業の戦略・SWOT・財務情報
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆